FARALLON CAPITAL MANAGEMENT LLC
Position in TNGX — Tango Therapeutics, Inc.
CIK 909661
SAN FRANCISCO, CA
Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$190,317,838
+$74,593,737 QoQ
Shares Held
9,097,411
-30.3% QoQ
Ownership
6.29%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FARALLON CAPITAL MANAGEMENT LLC holds $5,160,870,541 across 65 Biotechnology names. TNGX ranks #10 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,604,796 | $1,323,066,411 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
9,365,463 | $695,479,282 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $669,174,692 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,111,010 | $562,331,218 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,338,098 | $302,839,719 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
9,675,000 | $267,997,500 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,134,696 | $241,509,805 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
5,684,000 | $192,289,720 |
All Filings in TNGX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $190,317,838 | 9,097,411 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $115,724,101 | 13,061,411 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $90,358,800 | 10,757,000 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $46,883,840 | 9,157,000 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $6,316,974 | 4,610,930 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $12,360,000 | 4,000,000 | Shares | Other | 2025-02-14 | |
| 2022-12-31 | $1,957,500 | 270,000 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $1,086,000 | 300,000 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $1,359,000 | 300,000 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $2,274,000 | 300,000 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $3,282,000 | 300,000 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $3,879,000 | 300,000 | Shares | Other | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||